Almirall took home the Distinguished Corporate Leadership award by the American Skin Association (ASA).
Ron Menezes, President and General Manager of Almirall LLC, accepted the award and spoke about Almirall's new corporate purpose which aligns with ASA’s mission to advance research, champion skin health and drive public awareness about skin disease.
"This was a 16-year-old male patient with severe acne who was hiding away from the world," Menezes said in his acceptance speech. "He wouldn't meet the eyes of his dermatologist when he first visited them to get help. At his first follow-up visit four weeks later he already had a significant improvement, but more importantly he had 'come out of his shell' as his mother said. He was reaching out to friends again and was socializing, and she was relieved and happy to see that."
Dr. David Norris, University of Colorado professor and President of the board of directors for the ASA, presented Menezes with the Award. "I'm impressed with Almirall's spectrum of new treatments for important skin diseases, in some areas that we as clinicians haven't had new treatments in for years. Through pharmacological innovation and strong commitment to global healthcare partnerships, Almirall is dedicated to providing the tools, knowledge and science to improve the health of patients worldwide," he said.
Peter Guenter, CEO of Almirall SA, added, "We are pleased to have received this award from such an esteemed organization. The ASA mission aligns with the new Almirall corporate purpose: 'Transform the patients' world by helping them realize their hopes and dreams for a healthy life.' We look forward to working with them, and the rest of the dermatology community, to make this purpose a reality."